Skip to main content

Biologic

Biologic

Drug discovery to improve egg quality for next-generation IVF and assisted reproductive technologies

The Therapeutic Role of CELA2A in Type 2 Diabetes and Chronic Pancreatitis

Novel Target for Treatment of Myocardial Infarction

Stopping Post Menopausal Osteoporosis Before It Starts with a New Biologic: PREZERVE

A Therapeutic for Pterygium and Corneal Neovascularization

A therapeutic calcium channel blocking antibody for cancer

Development of a novel, phosphospecific alpha-synuclein antibody as a therapeutic for MSA​

Developing an ADC for treatment of glioma

Developing Catalytically Inactive CELA2A as a First-in-Class Therapy for Diabetes

First-in-class Nectin-2 targeting ADC for solid tumors

Subscribe to Biologic